Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.38 |
---|---|
High | 1.40 |
Low | 1.16 |
Bid | 1.17 |
Offer | 1.21 |
Previous close | 1.18 |
Average volume | 77.48k |
---|---|
Shares outstanding | 1.03m |
Free float | 1.01m |
P/E (TTM) | -- |
Market cap | 1.21m USD |
EPS (TTM) | -28.16 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:59 BST.
More ▼
Announcements
- 180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
- 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
- 180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- 180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
- 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
- 180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
- 180 Life Sciences Announces Review of Strategic Alternatives
More ▼